Junin Virus Vaccines

Author(s):  
D. A. Enria ◽  
J. G. Barrera Oro
Keyword(s):  
1983 ◽  
Vol 12 (4) ◽  
pp. 273-280 ◽  
Author(s):  
Mercedes C. Weissenbacher ◽  
Marta S. Sabattini ◽  
María M. Avila ◽  
Patricia M. Sangiorgio ◽  
María R. F. De Sensi ◽  
...  

Intervirology ◽  
1977 ◽  
Vol 8 (6) ◽  
pp. 360-363 ◽  
Author(s):  
Adriana Rabinovich ◽  
Patricio M. Cossio ◽  
Guadalupe Carballal ◽  
Roberto M. Arana

2011 ◽  
Vol 55 (10) ◽  
pp. 4631-4638 ◽  
Author(s):  
Benjamin W. Neuman ◽  
Lydia H. Bederka ◽  
David A. Stein ◽  
Joey P. C. Ting ◽  
Hong M. Moulton ◽  
...  

ABSTRACTMembers of theArenaviridaefamily are a threat to public health and can cause meningitis and hemorrhagic fever, and yet treatment options remain limited by a lack of effective antivirals. In this study, we found that peptide-conjugated phosphorodiamidate morpholino oligomers (PPMO) complementary to viral genomic RNA were effective in reducing arenavirus replication in cell cultures andin vivo. PPMO complementary to the Junín virus genome were designed to interfere with viral RNA synthesis or translation or both. However, only PPMO designed to potentially interfere with translation were effective in reducing virus replication. PPMO complementary to sequences that are highly conserved across the arenaviruses and located at the 5′ termini of both genomic segments were effective against Junín virus, Tacaribe virus, Pichinde virus, and lymphocytic choriomeningitis virus (LCMV)-infected cell cultures and suppressed viral titers in the livers of LCMV-infected mice. These results suggest that arenavirus 5′ genomic termini represent promising targets for pan-arenavirus antiviral therapeutic development.


2012 ◽  
Vol 59 (4) ◽  
pp. 278-285 ◽  
Author(s):  
M. Salazar ◽  
N. E. Yun ◽  
A. L. Poussard ◽  
J. N. Smith ◽  
J. K. Smith ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document